
About Mentice
Mentice is a publicly listed company based in Goteborg (Sweden) founded in 1999. Simulation solutions for cardiovascular and neurovascular physician training are provided. The company has 131 employees. Mentice has completed 4 acquisitions, including Biomodex, Medical Simulation Corporation and Vascular Simulations. Mentice offers products and services including Virtual Simulation, Flow Models, and Cloud Applications. Its focus areas include HealthTech, Healthcare IT, Provider and Administrative Solutions. Its legal entity is Mentice AB.
Company details
Mentice was founded in 1999 in Gothenburg, Sweden, and operates in the medical simulation sector. Cardiovascular and neurovascular training solutions are developed, including software, VIST simulator platforms, flow systems for vessels, and mobile applications. Hands-on procedural training for clinicians is supported through modules focused on catheter-based and minimally invasive vascular surgeries, with an emphasis on skill acquisition for improved patient safety.
Products & Services of Mentice
Mentice offers a comprehensive portfolio of products and services, including Virtual Simulation, Flow Models, and Cloud Applications.
VR simulators for interventional procedures and learning modules
Physical systems replicating vascular anatomy for device testing
Mobile apps for remote proctoring and procedural exploration
Apps and channels of Mentice
its YouTube channel Mentice has 2.7K subscribers and 30 videos.
Videos from Mentice
The most watched videos on Mentice's YouTube channel, Mentice (2.7K subscribers). Click a video to play it here.
More on Mentice.
Funding Insights of Mentice
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Mentice with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2006 | Series A | β | β |
1 investors in total: 1 institutional.
Investors in Mentice
Mentice has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Priveq.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Priveq is engaged in investing in unlisted growth companies. | 1998 | priveq.se | Stockholm, Sweden |
Investor details for Mentice
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Mentice
35 people are tracked at Mentice (20 in leadership, 6 in board & advisors, 9 in team); the tracked headcount is 131.
| Name | Role | Group |
|---|---|---|
Kjell Asserlind | VP & GM, EMEA/CIS | Leadership |
Jan Grund Pedersen | VP, Strategic Alliances & Business Development | Leadership |
Göran Malmberg | Group CEO & President | Leadership |
Henrik Storm | CTO | Leadership |
Cleber Veloso | Sales Director Latam | Leadership |
Maria Näslund | Sales Director | Leadership |
Pontus Appelqvist | VP And Gm, APAC | Leadership |
Tony C. | Director Strategic Global Accounts | Leadership |
Ulrika Drotz | CFO | Leadership |
Jonatan Sjöström | Chief Operating Officer | Leadership |
Hector Fernandez | Director Of Ankyras Software Development And PRRC At Mentice Spain S.l. | Leadership |
Alex H. | Vice President And General Manager, Americas | Leadership |
Andreas Danielsson | VP Of Sales Operations | Leadership |
Thomas Sunnanväder | Senior Director EMEA HCS | Leadership |
Lars Lonn | Clinical Director | Leadership |
Edward Faelt | Chief Strategy Officer (cso) | Leadership |
Renan Cancissu | Director Of Precision Medicine | Leadership |
Scott Black | Global Business Development Director | Leadership |
Jonathan Bosson | Innovation Director | Leadership |
Martin Harris | VP, Marketing | Leadership |
15 more people are available in the full profile.
Complete people profiles for Mentice
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Mentice
Mentice is a publicly listed company on the OMXSTO with ticker symbol MNTC in Sweden, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date20 Jun 2019
- Listed onSTO: MNTC
- Listed entityMentice AB
- Exchange sectorHealth technology
- ISINSE0012673291
- Share price14.70 SEK (-2.65% on the day) · 2026-10-13
- Market capitalisation413,448,289.00 SEK
- EPS (diluted, trailing year)-0.16 SEK
- Volume (last session)8,209
Financials of Mentice
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 279.1M SEK | -32.3M SEK | -1.7M SEK |
| 2024 | 290.3M SEK | -18.4M SEK | 16.7M SEK |
| 2023 | 273.6M SEK | -2.8M SEK | 25.5M SEK |
| 2022 | 217.9M SEK | -30.7M SEK | -3.4M SEK |
| 2021 | 185.1M SEK | -29.2M SEK | -2.7M SEK |
Detailed financial statements for Mentice
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Mentice
Mentice has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Biomodex, Medical Simulation Corporation and Vascular Simulations.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
3D printed surgical simulators for medical education and patient-specific preoperative planning | biomodex.com | Paris, France | 2014 | Jan 2023 | $217,684 | |
Endovascular simulators are developed for surgical navigation and planning. | vascularsimulations.com | Stony Brook, United States | 2011 | Nov 2020 | β’β’β’β’ | |
Provider of a web-based application for patient record management for radiologist | myirlog.com | United States | 2016 | Oct 2020 | β’β’β’β’ | |
Simulation-based training products are provided for healthcare professionals. | medsimulation.com | Denver, United States | 1998 | Dec 2017 | β’β’β’β’ |
Complete acquisition details for Mentice
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Mentice
7 dated milestones of Mentice across 24 years, from founding to its latest funding, stage changes and deals.
- Founded Mentice is founded.
- Funding First funding round.
- Acquisition Acquires Medical Simulation Corporation.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires my IR log.
- Acquisition Acquires Vascular Simulations.
- Acquisition Acquires Biomodex.
Web traffic of Mentice
The website of Mentice (mentice.com) receives about 4.7K visits a month.
- Monthly visits4.7K
▼ 30% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Mentice
Complete news archive for Mentice
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mentice
Mentice was founded in 1999 and raised its 1st funding round 7 years after it was founded.
Mentice is headquartered in Goteborg, Sweden. It is registered at Goteborg, Vastra Gotaland, Sweden.
Mentice has 131 employees.
Annual revenue of Mentice is $30.3M as on Dec 31, 2025.
Mentice was founded in 1999 in Gothenburg, Sweden, and operates in the medical simulation sector. Cardiovascular and neurovascular training solutions are developed, including software, VIST simulator platforms, flow systems for vessels, and mobile applications. Hands-on procedural training for clinicians is supported through modules focused on catheter-based and minimally invasive vascular surgeries, with an emphasis on skill acquisition for improved patient safety.
Mentice offers Virtual Simulation, Flow Models, and Cloud Applications.
Yes, Mentice is publicly traded on OMXSTO under the ticker symbol MNTC.
Mentice has made 4 acquisitions, including Biomodex, Medical Simulation Corporation, and Vascular Simulations.
Mentice has 1 investor. Key investors include Priveq.
Mentice operates through Mentice Ab.
